Sentences with phrase «based precision medicine»
We are pioneering a new era of microbiome - based precision medicine.
https://www.mindbodygreen.com/ Not exact matches
• Aspire Universal, a Lancaster, Penn. - based private equity firm, is raising $ 300 million for its precision medicine fund, Aspire Ventures Precision Medicimedicine fund, Aspire Ventures Precision MedicineMedicine Fund.
• Syapse, a Palo Alto, Calif. - based developer of precision medicine software, raised $ 30 million in Series D funding.
Paul Black lists out three big trends to watch for in health IT this year, namely: a continuing shift to value - based care models (rather than the fee - for - service, volume - oriented paradigm which still dominates the sector); digital health infrastructure interoperability that makes it possible for different systems to talk to each other and coordinate care; and an increased focus on precision medicine and «genomically aware care» that can help take a lot of the guesswork out of medicine.
«Rheumatoid arthritis meets precision medicine: For first time scientists on way to predicting which drugs will help patients based on genetic profile of disease.»
Dr Fiona Blackhall, a senior lecturer in The University of Manchester's Institute of Cancer Sciences and a consultant based at The Christie NHS Foundation Trust — both part of the Manchester Cancer Research Centre — said: «In order to introduce precision medicine, where each cancer patient receives treatment designed to target the genetic makeup of their individual cancer, we need to compare how effective the new targeted treatment is compared to standard chemotherapy treatment.»
The new findings could be used to inform precision - medicine approaches that help minimize a person's risk for common diseases — such as diabetes, cardiovascular disease and cancer — by tailoring diet - based prevention and therapy to the specific needs of an individual.
The findings, which came out online June 26, 2015, in the journal Neuropsychopharmacology, are hopeful news amid a new national push toward «precision medicine,» in which doctors will tailor drug regimens and other treatments based on patients» individual gene profiles or other factors.
This therapy is a leading example of precision medicine, where treatment is based on a test for genetic mutations.
The cancer moonshot has begun to change that, he said, citing NCI's cloud - based Genomic Data Commons, a data repository meant to encourage researchers on different studies to share cancer genomic data to advance precision medicine.
As part of the precision medicine initiative at the Cancer Institute of New Jersey, investigators — which include colleagues from Rutgers Robert Wood Johnson Medical School and RUCDR Infinite Biologics, the world's largest university - based biorepository, located within the Human Genetics Institute of New Jersey — wanted to define the relationship of ERBB2 alterations in the pleomorphic form of the disease.
The findings, published online the week of March 21 in the journal Proceedings of the National Academy of Sciences, demonstrate that nanoparticle - based therapies can act as a «precision medicine» for targeting tumors while leaving healthy tissue intact.
Based in the Washington D.C. Metro area, BioFortis is a leading provider of precision medicine technology solutions.
July 7, 2016 UChicago to support NIH million - person precision medicine study The University of Chicago is one of three Illinois academic institutions that will work together to help launch President Obama's Precision Medicine Initiative (PMI) Cohort Program to enroll 1 million or more participants in a national research effort designed to find better ways to prevent and treat disease based on lifestyle, environment and gmedicine study The University of Chicago is one of three Illinois academic institutions that will work together to help launch President Obama's Precision Medicine Initiative (PMI) Cohort Program to enroll 1 million or more participants in a national research effort designed to find better ways to prevent and treat disease based on lifestyle, environment and gMedicine Initiative (PMI) Cohort Program to enroll 1 million or more participants in a national research effort designed to find better ways to prevent and treat disease based on lifestyle, environment and genetics.
The tests are based on research conducted by Columbia University Irving Medical Center (CUIMC) investigators — and could pave the way for a more precise approach to cancer therapy and help find effective drugs when conventional approaches to precision medicine have failed.
LOS ANGELES, Calif. & BOSTON, Mass. — Scientists at Cedars - Sinai and Emulate, Inc. are pioneering a Patient - on - a-Chip program to help predict which disease treatments would be most effective based on a patient's genetic makeup and disease variant — a new approach to precision medicine for improving patient care and health.
Based on the results of multiple studies, Mylotarg was restored to the market in September, and researchers worldwide are pursuing a precision - medicine approach — targeting the drug to patients most likely to benefit — based on Meshinchi and colleagues» resBased on the results of multiple studies, Mylotarg was restored to the market in September, and researchers worldwide are pursuing a precision - medicine approach — targeting the drug to patients most likely to benefit — based on Meshinchi and colleagues» resbased on Meshinchi and colleagues» results.
The difference in expression patterns of individual cancers observed in the study strongly reinforces the need for personalized cancer treatment based on precision medicine.
The Human Emulation System offers researchers a new standard for predicting how a human may respond to diseases, medicines, chemicals, and foods — with greater precision and control than today's cell culture or animal - based testing approaches.
For example, the translational laboratory is providing support to a precision medicine - based clinical trial for patients with early - stage, triple - negative breast cancer.
«Advancing precision medicine with an NGS - based companion diagnostic test to support multiple NSCLC drug therapies» «Successes, challenges and future directions in other areas of clinical research»
Using a rapid learning approach, the goal of M2Gen is to accelerate the science of precision medicine by creating evidence and knowledge - based solutions that identify a patient's susceptibility to disease, predict how the patient will respond to a particular drug, and match patients to the best therapies for an optimal treatment outcome.
Based on the remarkable success of the original technology - focused AGBT meeting — and with an eye towards facilitating the emergence of a new era of precision medicine — The Genome Partnership launched AGBT - Precision Health, a new conference that debuted in September of 2016, in Scottsdale, Arizona.
The Center for Cancer Targeted Therapies (C2T2) integrates a phase I - Ib / early clinical trials program, a precision cancer medicine infrastructure with expertise on tumor tissue - based state - of - the - art molecular methods, and a core resource with novel non-invasive functional imaging methods.
This article discusses the practical requirements and challenges of developing such new precision medicine strategies, based on leveraging complex genomic profiles, as discussed at the Innovation and Biomarkers in Cancer Drug Development meeting (8th - 9th September 2016, Brussels, Belgium).
The bioconjugate has applications in combination and theranostic treatments for cancer, and in precision medicine to diversify targeting based on patient - specific panomics analyses.
Team collaboration launch of Target Now Registry aimed to act as a robust information catalyst, advancing precision medicine in oncology through the broad - based acquisition and sharing of valuable molecular, clinical and outcomes data, while collaborating on a national level in a secure, community - based environment.